BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19251804)

  • 1. Lysosomal iron in pulmonary alveolar proteinosis: a case report.
    Persson HL; Vainikka LK
    Eur Respir J; 2009 Mar; 33(3):673-9. PubMed ID: 19251804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha preserves lysosomal stability in macrophages: a potential defense against oxidative lung injury.
    Persson HL; Vainikka LK
    Toxicol Lett; 2010 Feb; 192(2):261-7. PubMed ID: 19900513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α-stimulated macrophages protect A549 lung cells against iron and oxidation.
    Persson HL; Vainikka LK; Eriksson I; Wennerström U
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):81-9. PubMed ID: 21741805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lane-Hamilton syndrome: ferritin protects lung macrophages against iron and oxidation.
    Persson HL; Vainikka LK; Eriksson HB; Wennerström U
    Chest; 2011 Feb; 139(2):361-367. PubMed ID: 20705801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages.
    Persson HL
    Toxicol Lett; 2005 Nov; 159(2):124-33. PubMed ID: 15949905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant proteins in pulmonary alveolar proteinosis in adults.
    Brasch F; Birzele J; Ochs M; Guttentag SH; Schoch OD; Boehler A; Beers MF; Müller KM; Hawgood S; Johnen G
    Eur Respir J; 2004 Sep; 24(3):426-35. PubMed ID: 15358702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary alveolar proteinosis].
    Hutyrová B
    Vnitr Lek; 2007 Oct; 53(10):1077-84. PubMed ID: 18072433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lavage fluid from a patient with alveolar proteinosis inhibits the in vitro chemiluminescence response and arachidonic acid metabolism of normal guinea pig alveolar macrophages.
    Carre PC; Didier AP; Pipy BR; Forgue MF; Beraud MF; Meeus EP; Caratero AL; Leophonte PJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1068-72. PubMed ID: 2122784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron.
    Kurz T; Terman A; Brunk UT
    Arch Biochem Biophys; 2007 Jun; 462(2):220-30. PubMed ID: 17306211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of surfactant protein production in a mouse model of secondary pulmonary alveolar proteinosis.
    Shibasaki M; Hashimoto K; Okamoto M; Hayashi Y; Imaizumi K; Hashimoto N; Ozaki N; Yokoi T; Takagi K; Hasegawa Y; Shimokata K; Kawabe T
    Am J Respir Cell Mol Biol; 2009 May; 40(5):536-42. PubMed ID: 18931325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary alveolar proteinosis.
    Khan A; Agarwal R
    Respir Care; 2011 Jul; 56(7):1016-28. PubMed ID: 21496372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-macrophage colony-stimulating factor and pulmonary surfactant homeostasis.
    Reed JA; Whitsett JA
    Proc Assoc Am Physicians; 1998; 110(4):321-32. PubMed ID: 9686680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary alveolar proteinosis].
    Floarea-Strat A; Stanciu A; Creţeanu M
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):518-23. PubMed ID: 14756054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug.
    Wardwell NR; Miller R; Ware LB
    Respirology; 2006 Sep; 11(5):663-5. PubMed ID: 16916345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Gallium Arsenide (CAS No. 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Sep; 492():1-306. PubMed ID: 12563348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).
    Barna BP; Malur A; Dalrymple H; Karnekar R; Culver DA; Abraham S; Singh RJ; Brescia D; Kavuru MS; Thomassen MJ
    Autoimmunity; 2009 Jan; 42(1):56-62. PubMed ID: 18803071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.